Ledger.Open graph →
SEC Form D · filed December 30, 2021

Can-Fite BioPharma Ltd

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PETACH TIKVA, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Yossi Bornstein · Petach Tikva, L3DirectorTacey R. Viegas · Madison, ALExec · DirectorYaacov Goldman · Yokne'am Illit, L3DirectorSteven Eisner · San Francisco, CADirectorIlan Cohn · Petach Tikva, L3DirectorMotti Farbstein · Petach Tikva, L3ExecPnina Fishman · Petach Tikva, L3Exec · DirectorTerry Ransford · Chicago, ILDirectorKevin J. Ritterman · Fargo, NDExecYossi Bornstein · Petach Tikva, L3DirectorJames R. Hudson, Jr · Huntsville, ALDirectorBarbara M. Fisk · Madison, ALDirectorAbraham Sartani · Petach Tikva, L3DirectorGuy Regev · Petach Tikva, L3DirectorMichael J. Mcvean · Dallas, TXDirectorJanon Costly · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗